Exagen (XGN)
(Delayed Data from NSDQ)
$2.95 USD
-0.13 (-4.22%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $2.92 -0.03 (-1.02%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth F Momentum C VGM
Exagen Inc. (XGN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$6.25 | $8.00 | $5.00 | 102.92% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for Exagen Inc. comes to $6.25. The forecasts range from a low of $5.00 to a high of $8.00. The average price target represents an increase of 102.92% from the last closing price of $3.08.
Analyst Price Targets (4 )
Broker Rating
Exagen Inc. currently has an average brokerage recommendation (ABR) of 1.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.33 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, five are Strong Buy, representing 83.33% of all recommendations. A month ago, Strong Buy represented 83.33%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/XGN.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/28/2024 | Canaccord Genuity | Kyle Mikson | Strong Buy | Strong Buy |
5/14/2024 | William Blair | Andrew F Brackmann | Strong Buy | Strong Buy |
5/14/2024 | Cantor Fitzgerald & Co | Ross Osborn | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Daniel Brennan | Strong Buy | Strong Buy |
3/15/2024 | KeyBanc Capital Markets | Paul Knight | Hold | Hold |
1/7/2024 | BTIG | Mark Massaro | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.33 |
ABR (Last week) | 1.33 |
# of Recs in ABR | 6 |
Average Target Price | $6.25 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 81 of 253 |
Current Quarter EPS Est: | -0.30 |
XGN FAQs
Exagen Inc. (XGN) currently has an average brokerage recommendation (ABR) of 1.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 6 brokerage firms.
The average price target for Exagen Inc. (XGN) is $6.25. The current on short-term price targets is based on 2 reports.
The forecasts for Exagen Inc. (XGN) range from a low of $5 to a high of $8. The average price target represents a increase of $111.86 from the last closing price of $2.95.
The current UPSIDE for Exagen Inc. (XGN) is 111.86%
Based on short-term price targets offered by four analysts, the average price target for Exagen Inc. comes to $6.25. The forecasts range from a low of $5.00 to a high of $8.00. The average price target represents an increase of 102.92% from the last closing price of $3.08.